HK Stock MarketDetailed Quotes

02009 BBMG

Watchlist
  • 0.650
  • -0.030-4.41%
Market Closed Apr 30 16:08 CST
6.94BMarket Cap-6632P/E (TTM)

BBMG Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Turnover
-45.34%12.83B
4.99%107.96B
-8.77%72.6B
-10.72%49.14B
1.72%23.48B
-16.83%102.82B
-8.96%79.58B
-4.64%55.03B
0.63%23.08B
14.47%123.63B
Operating income
-45.34%12.83B
4.99%107.96B
-8.77%72.6B
-10.72%49.14B
1.72%23.48B
-16.83%102.82B
-8.96%79.58B
-4.64%55.03B
0.63%23.08B
14.47%123.63B
Operating expenses
42.17%-12.33B
-9.72%-95.97B
3.48%-64.74B
6.48%-43.62B
-8.14%-21.31B
15.54%-87.47B
8.35%-67.07B
2.76%-46.65B
-1.53%-19.71B
-18.42%-103.56B
Gross profit
-76.61%506.79M
-21.96%11.98B
-37.19%7.85B
-34.27%5.51B
-35.80%2.17B
-23.49%15.36B
-12.10%12.5B
-13.91%8.39B
-4.29%3.37B
-2.34%20.07B
Selling expenses
11.69%-514.76M
-1.18%-2.4B
-4.21%-1.83B
-0.91%-1.14B
4.60%-582.87M
10.87%-2.37B
-13.01%-1.75B
2.74%-1.13B
0.94%-610.96M
-13.69%-2.66B
Administrative expenses
-7.11%-1.59B
5.64%-6.57B
9.04%-4.35B
-1.32%-3.27B
3.86%-1.48B
-1.69%-6.96B
-3.67%-4.78B
-7.18%-3.22B
3.52%-1.54B
-7.92%-6.84B
Research and development expenses
-27.56%-133.09M
-29.27%-530.17M
-12.47%-475.98M
-32.88%-261M
-35.70%-104.34M
-18.29%-410.14M
-19.33%-423.21M
-9.37%-196.41M
2.36%-76.89M
-28.82%-346.73M
Profit from asset sales
-73.46%45.78M
-12.09%1.15B
1,327.75%650.49M
1,291.51%619.72M
13.98%172.53M
1,668.85%1.31B
-0.36%45.56M
20.57%44.54M
-55.04%151.37M
53,222.57%73.87M
Revaluation surplus
82.80%23.95M
100.11%1.17B
5.56%338.62M
9.02%336.7M
221.63%13.1M
-15.72%583.06M
23.71%320.78M
28.28%308.85M
104.13%4.07M
32.94%691.81M
-Changes in the fair value of other assets
82.80%23.95M
100.11%1.17B
5.56%338.62M
9.02%336.7M
221.63%13.1M
-15.72%583.06M
23.71%320.78M
28.28%308.85M
104.13%4.07M
32.94%691.81M
Impairment and provision
284.18%38.38M
-54.74%-1.98B
73.24%-50.98M
-33.80%-150.14M
-292.70%-20.84M
6.06%-1.28B
-10.32%-190.54M
37.36%-112.22M
335.10%10.81M
-26.73%-1.36B
-Other impairment is provision
284.18%38.38M
-54.74%-1.98B
73.24%-50.98M
-33.80%-150.14M
-292.70%-20.84M
6.06%-1.28B
-10.32%-190.54M
37.36%-112.22M
335.10%10.81M
-26.73%-1.36B
Special items of operating profit
338.88%406.14M
-18.45%705.26M
-20.17%552.06M
-15.89%363.26M
87.62%92.54M
-48.29%864.84M
-22.50%691.56M
-40.27%431.91M
-65.87%49.32M
6.65%1.67B
Operating profit
-2,433.69%-1.23B
-58.19%2.43B
-60.39%2.1B
-55.38%1.65B
-105.69%-48.66M
-38.97%5.82B
-30.08%5.3B
-31.67%3.69B
-34.43%855.83M
-9.98%9.53B
Financing cost
-12.31%-780.83M
15.35%-2.28B
-5.11%-2.08B
14.53%-1.3B
-22.08%-695.24M
-13.34%-2.69B
-9.54%-1.98B
-11.11%-1.52B
20.82%-569.49M
24.96%-2.37B
Special items of earning before tax
44.81%26.53M
-26.52%144.02M
-92.79%81.31M
-93.93%72.6M
-39.56%18.32M
-72.84%195.99M
89.37%1.13B
220.53%1.2B
-37.92%30.31M
96.44%721.54M
Earning before tax
-173.87%-1.99B
-90.97%300.39M
-97.66%103.97M
-87.39%425.68M
-329.14%-725.58M
-57.81%3.33B
-30.13%4.45B
-23.56%3.37B
-50.13%316.65M
1.10%7.88B
Tax
20.68%-93.26M
-0.17%-1.59B
61.46%-522.85M
56.96%-411.02M
23.06%-117.58M
40.58%-1.59B
24.61%-1.36B
20.10%-954.98M
31.38%-152.82M
-1.11%-2.67B
After-tax profit from continuing operations
-146.74%-2.08B
-173.99%-1.29B
-113.54%-418.88M
-99.39%14.66M
-614.66%-843.15M
-66.62%1.74B
-32.30%3.09B
-24.85%2.42B
-60.26%163.83M
1.10%5.21B
Earning after tax
-146.74%-2.08B
-173.99%-1.29B
-113.54%-418.88M
-99.39%14.66M
-614.66%-843.15M
-66.62%1.74B
-32.30%3.09B
-24.85%2.42B
-60.26%163.83M
1.10%5.21B
Minority profit
-50.89%-771.81M
-348.98%-1.31B
-156.16%-429.49M
-167.71%-395.4M
-357.32%-511.5M
-76.87%527.21M
-58.76%764.79M
-55.34%583.95M
-158.48%-111.85M
-1.40%2.28B
Profit attributable to shareholders
-294.57%-1.31B
-97.92%25.26M
-99.54%10.61M
-77.66%410.06M
-220.30%-331.65M
-58.65%1.21B
-14.25%2.33B
-3.99%1.84B
24.77%275.67M
3.14%2.93B
Basic earnings per share
-300.00%-0.12
-98.18%0.002
-98.08%0.0025
-200.00%-0.03
-59.26%0.11
-7.14%0.13
50.00%0.03
0.00%0.27
Diluted earnings per share
-300.00%-0.12
-98.18%0.002
-98.08%0.0025
-200.00%-0.03
-59.26%0.11
-7.14%0.13
50.00%0.03
0.00%0.27
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Turnover -45.34%12.83B4.99%107.96B-8.77%72.6B-10.72%49.14B1.72%23.48B-16.83%102.82B-8.96%79.58B-4.64%55.03B0.63%23.08B14.47%123.63B
Operating income -45.34%12.83B4.99%107.96B-8.77%72.6B-10.72%49.14B1.72%23.48B-16.83%102.82B-8.96%79.58B-4.64%55.03B0.63%23.08B14.47%123.63B
Operating expenses 42.17%-12.33B-9.72%-95.97B3.48%-64.74B6.48%-43.62B-8.14%-21.31B15.54%-87.47B8.35%-67.07B2.76%-46.65B-1.53%-19.71B-18.42%-103.56B
Gross profit -76.61%506.79M-21.96%11.98B-37.19%7.85B-34.27%5.51B-35.80%2.17B-23.49%15.36B-12.10%12.5B-13.91%8.39B-4.29%3.37B-2.34%20.07B
Selling expenses 11.69%-514.76M-1.18%-2.4B-4.21%-1.83B-0.91%-1.14B4.60%-582.87M10.87%-2.37B-13.01%-1.75B2.74%-1.13B0.94%-610.96M-13.69%-2.66B
Administrative expenses -7.11%-1.59B5.64%-6.57B9.04%-4.35B-1.32%-3.27B3.86%-1.48B-1.69%-6.96B-3.67%-4.78B-7.18%-3.22B3.52%-1.54B-7.92%-6.84B
Research and development expenses -27.56%-133.09M-29.27%-530.17M-12.47%-475.98M-32.88%-261M-35.70%-104.34M-18.29%-410.14M-19.33%-423.21M-9.37%-196.41M2.36%-76.89M-28.82%-346.73M
Profit from asset sales -73.46%45.78M-12.09%1.15B1,327.75%650.49M1,291.51%619.72M13.98%172.53M1,668.85%1.31B-0.36%45.56M20.57%44.54M-55.04%151.37M53,222.57%73.87M
Revaluation surplus 82.80%23.95M100.11%1.17B5.56%338.62M9.02%336.7M221.63%13.1M-15.72%583.06M23.71%320.78M28.28%308.85M104.13%4.07M32.94%691.81M
-Changes in the fair value of other assets 82.80%23.95M100.11%1.17B5.56%338.62M9.02%336.7M221.63%13.1M-15.72%583.06M23.71%320.78M28.28%308.85M104.13%4.07M32.94%691.81M
Impairment and provision 284.18%38.38M-54.74%-1.98B73.24%-50.98M-33.80%-150.14M-292.70%-20.84M6.06%-1.28B-10.32%-190.54M37.36%-112.22M335.10%10.81M-26.73%-1.36B
-Other impairment is provision 284.18%38.38M-54.74%-1.98B73.24%-50.98M-33.80%-150.14M-292.70%-20.84M6.06%-1.28B-10.32%-190.54M37.36%-112.22M335.10%10.81M-26.73%-1.36B
Special items of operating profit 338.88%406.14M-18.45%705.26M-20.17%552.06M-15.89%363.26M87.62%92.54M-48.29%864.84M-22.50%691.56M-40.27%431.91M-65.87%49.32M6.65%1.67B
Operating profit -2,433.69%-1.23B-58.19%2.43B-60.39%2.1B-55.38%1.65B-105.69%-48.66M-38.97%5.82B-30.08%5.3B-31.67%3.69B-34.43%855.83M-9.98%9.53B
Financing cost -12.31%-780.83M15.35%-2.28B-5.11%-2.08B14.53%-1.3B-22.08%-695.24M-13.34%-2.69B-9.54%-1.98B-11.11%-1.52B20.82%-569.49M24.96%-2.37B
Special items of earning before tax 44.81%26.53M-26.52%144.02M-92.79%81.31M-93.93%72.6M-39.56%18.32M-72.84%195.99M89.37%1.13B220.53%1.2B-37.92%30.31M96.44%721.54M
Earning before tax -173.87%-1.99B-90.97%300.39M-97.66%103.97M-87.39%425.68M-329.14%-725.58M-57.81%3.33B-30.13%4.45B-23.56%3.37B-50.13%316.65M1.10%7.88B
Tax 20.68%-93.26M-0.17%-1.59B61.46%-522.85M56.96%-411.02M23.06%-117.58M40.58%-1.59B24.61%-1.36B20.10%-954.98M31.38%-152.82M-1.11%-2.67B
After-tax profit from continuing operations -146.74%-2.08B-173.99%-1.29B-113.54%-418.88M-99.39%14.66M-614.66%-843.15M-66.62%1.74B-32.30%3.09B-24.85%2.42B-60.26%163.83M1.10%5.21B
Earning after tax -146.74%-2.08B-173.99%-1.29B-113.54%-418.88M-99.39%14.66M-614.66%-843.15M-66.62%1.74B-32.30%3.09B-24.85%2.42B-60.26%163.83M1.10%5.21B
Minority profit -50.89%-771.81M-348.98%-1.31B-156.16%-429.49M-167.71%-395.4M-357.32%-511.5M-76.87%527.21M-58.76%764.79M-55.34%583.95M-158.48%-111.85M-1.40%2.28B
Profit attributable to shareholders -294.57%-1.31B-97.92%25.26M-99.54%10.61M-77.66%410.06M-220.30%-331.65M-58.65%1.21B-14.25%2.33B-3.99%1.84B24.77%275.67M3.14%2.93B
Basic earnings per share -300.00%-0.12-98.18%0.002-98.08%0.0025-200.00%-0.03-59.26%0.11-7.14%0.1350.00%0.030.00%0.27
Diluted earnings per share -300.00%-0.12-98.18%0.002-98.08%0.0025-200.00%-0.03-59.26%0.11-7.14%0.1350.00%0.030.00%0.27
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg